综述:微循环在肝硬化中的作用
本文综述了微循环在肝硬化及其并发症病理生理中的作用。通过Medline检索相关文献,发现肝硬化患者存在显著的异质性微血管改变,全身炎症可诱导微循环失调并参与血流动力学紊乱,全身肝外微血管的血管收缩和低灌注可能参与失代偿期肝硬化器官衰竭的病理生理。进一步研究微循环可能为实时评估个体对血管活性药物的微循环反应提供平台,从而指导治疗。
要点
- 肝硬化患者存在显著的异质性微血管改变。
- 晚期肝硬化相关的全身炎症可诱导微循环失调并参与血流动力学紊乱。
- 全身肝外微血管的血管收缩和低灌注可能参与失代偿期肝硬化器官衰竭的病理生理。
核心结论
- 进一步研究微循环在肝硬化患者中的作用将提高医生对肝硬化病理生理的理解,并可能为实时评估个体对血管活性介质的微循环反应提供平台,从而指导治疗。
研究设计与样本
- 本文为综述,采用Medline文献检索,检索词包括「cirrhosis」「microcirculation」「circulation」「systemic」「inflammation」「peripheral」「hepatorenal」和「hepatopulmonary」。
主要发现
- 肝硬化患者存在显著的异质性微血管改变。
- 数据提示与晚期肝硬化相关的全身炎症可诱导微循环失调并参与血流动力学紊乱。
- 全身肝外微血管中由此产生的血管收缩和低灌注可能对失代偿期肝硬化器官衰竭的病理生理起重要作用,但用于纠正晚期肝硬化循环障碍的血管活性药物的机制作用尚不清楚。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrahepatic microvascular derangements and microcirculatory dysfunction are key in the development of liver cirrhosis and its associated complications. While much has been documented relating to cirrhosis and the dysfunction of the microcirculation in the liver parenchyma, far less is known about the state of the extrahepatic microcirculation and the role this may have in the pathogenesis of multiple organ failure in end stage liver cirrhosis. AIM: To provide an update on the role of the microcirculation in the pathophysiology of cirrhosis and its associated complications and briefly discuss some of the imaging techniques which may be used to directly investigate the microcirculation. METHODS: A Medline literature search was conducted using the following search terms: 'cirrhosis', 'microcirculation', 'circulation', 'systemic', 'inflammation', 'peripheral', 'hepatorenal' and 'hepatopulmonary'. RESULTS: Significant heterogeneous microvascular alterations exist in patients with cirrhosis. Data suggest that the systemic inflammation, associated with advanced cirrhosis, induces microcirculatory dysregulation and contributes to haemodynamic derangement. The resultant vasoconstriction and hypoperfusion in the systemic extrahepatic microvasculature, is likely to be instrumental in the pathophysiology of organ failure in decompensated cirrhosis, however the mechanistic action of vasoactive agents used to correct the circulatory disturbance of advanced cirrhosis is poorly understood. CONCLUSIONS: Further research into the role of the microcirculation in patients with liver cirrhosis, will improve physicians understanding of the pathophysiology of cirrhosis, and may provide a platform for real time evaluation of an individual's microcirculatory response to vasoactive mediators, thus guiding their therapy.
引用
- Davies T, Wythe S, O'Beirne J, et al. Review article: the role of the microcirculation in liver cirrhosis. Aliment Pharmacol Ther. 2017. PMID: 29023881. doi:10.1111/apt.14279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。